AzTrials
AzTrials

DementiaNCT04139707

A Mobile Application for Training of Family Caregivers Caring for Someone With Dementia

A study testing Caring4Dementia and White Paper in people with Dementia, run by University of Manitoba at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Background The mental, physical, and emotional health of caregivers is negatively affected by the burden of caring for of persons living with dementia. Caregivers are usually reported as feeling frustrated, angry, exhausted, guilty, helpless and unable to bear the heavy burden of their caregiving responsibilities. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Dementia
What is being tested?
Caring4Dementia and White Paper
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteCanada
Study dates
2 Jan 2020to 31 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Informal caregiver of a person living with dementia for more than 6 months
  • Able to read and understand English
  • Able to use smartphones and tablets (Apple or Android)
  • Have a smartphone or tablet (Apple or Android) with internet connection, involved in this study
  • 18 years or over
  • Give written and oral informed consent

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

Amine Choukou, PhD contact

+12047893412

amine.choukou@umanitoba.ca

Canada1 site, 1 recruiting
  • Riverview Health Centre

    Winnipeg, Manitoba

    M Klassen

    Recruiting

Other trials in Canada

About this study

Official title: An Information and Computer Technology-based Mobile Application for Training of Family Members Caring for Someone With Dementia

Background

The mental, physical, and emotional health of caregivers is negatively affected by the burden of caring for of persons living with dementia. Caregivers are usually reported as feeling frustrated, angry, exhausted, guilty, helpless and unable to bear the heavy burden of their caregiving responsibilities. In addition to depressive symptoms and other mental health problems among caregivers, the physical stress of caring for someone who is unable to perform daily activities such as bathing, grooming and other personal care, has been shown to be a serious threat to caregivers' physical health outcomes. Evidence has shown that greater levels of stress, anxiety, depression, frustration, and lower subjective well-being and self-efficacy are exhibited in a greater amount among family and friends who care for persons living with dementia compared to those who do not have the burden of caring for a persons living with dementia. Caregivers have been shown to use alcohol and other drugs at a higher rate than those who do not need to care for others as a reaction to this increased stress. Studies has also shown that caregivers are more likely than non-Caregivers to use opioid or psychotropic medications. One over five caregivers (22%) feel tired when they go to bed at night.

Read more

Objectives

This study relies on a mobile application (Caring4Dementia) that provides people, caring for a person living with dementia, with a useful and intuitive training tool targeting communication skills. The aims of this study are to evaluate the feasibility and acceptability of using Caring4Dementia within a self-administered program and the preliminary efficacy of the Caring4Dementia intervention.

Conditions
Dementia
Being tested
Caring4Dementia, White Paper
Keywords
dementia, care-giving, communication, mobile application
Medical subject headings
Dementia, Communication

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Caring4DementiaDevice

    A mobile application administered for 30 days, which provides people caring for a person living with dementia with a useful and intuitive tool targeting communication skills.

  • White PaperOther

    The White Paper group will receive a white paper (hard copy and electronically) on the principles of communicating efficiently with persons living with dementia.

Study groups in NCT04139707
Study groupRoleWhat they receive
Caring4Dementia GroupExperimentalThe experimental group will receive Careing4Dementia downloadable on their smartphone or tablet. Caring4Dementia will tell and show caregivers of a person living with dementia how to 1) manage difficult behaviors, 2) deal with refusal, 3) deal with tensions and 4) manage work-life demands. The app is self-administered and self-paced and contains surveys referring to the outcome measurements tools used in the study. The intervention will be for 30 days without any restriction or limitation in terms of timing, location or frequency of use.
Receives: Device: Caring4Dementia
White Paper GroupActive comparatorThe White Paper group will receive a white paper on the principles of communicating efficiently with persons living with dementia.
Receives: Other: White Paper
Control GoupNo interventionThe control group will not receive any intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in caregiver well-being

    Measured by the Caregiver Well-Being Scale to determine the frequency in which basic needs and activities of living have been met for the caregiver within the last three months. Items in this self-reported scale are scored on a 5-point scale [ranging form "Rarely (1)" to "Usually (5)"], with a higher dimension score indicating greater intensity in that dimension. The highest score possible is 70, meaning a higher well-being.

    Measured: Baseline (Day 1), post (day 30), Retention (90 days) after baseline

Secondary outcomes (4)
  1. Change in caregiver burden

    Measured by the Short version of the Burden Scale for Family Caregivers. This is a 10-item instrument. Each item is a statement that is rated on a 4-point scale with the values "strongly disagree" (0), "disagree" (1), "agree" (2), and "strongly agree" (3). The scale ranges from 0 to 30, with a higher dimension score indicating greater intensity in that dimension.

    Measured: Baseline (Day 1), post (day 30), Retention (90 days) after baseline

  2. Change in caregivers' perceived challenges and resources

    Measured by the Adult Carer Quality of Life Questionnaire, a 40-item instrument that measures the overall quality of life for adult carers, and subscale scores for eight domains of quality of life. Scores on the overall questionnaire have a possible range of 0 to 120 with higher scores indicating greater quality of life.

    Measured: Baseline (Day 1), post (day 30), Retention (90 days) after baseline

  3. Activity volume on the Caring4Dementia app

    Usage logs will be saved on the cloud to quantify the time (s) spent on every activity for all the activities.

    Measured: 30 days

  4. Activity frequency on the Caring4Dementia app

    Usage logs will be saved on the cloud to quantify the frequency of use of every activity in the application for all the activities (how many time per day the caregiver engage in the activity).

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2019
  2. Study start2 Jan 2020
  3. Primary completion31 Jul 2020 (estimated)
  4. Study completion31 Jul 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Pilot Randomized Controlled Trial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04139707
Sponsor's protocol ID
HS23111 (H2019:319)
Status last verified
Mar 2020
First submitted
21 Oct 2019
Last updated
24 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Caring4Dementia and White Paper in people with Dementia, run by University of Manitoba at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Amine Choukou, PhD (+12047893412, amine.choukou@umanitoba.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in caregiver well-being (time frame: Baseline (Day 1), post (day 30), Retention (90 days) after baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in